Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Injection”

856 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 856 results

Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Post-approval studies (Phase 4)UnknownNCT05109000
What this trial is testing

Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline

Who this might be right for
Injection Site IrritationInjection Site BruisingInjection Site Discomfort+2 more
Jeffrey Alan Klein, MD 32
Early research (Phase 1)Study completedNCT07051538
What this trial is testing

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 64
Early research (Phase 1)Study completedNCT04408963
What this trial is testing

Trial to Evaluate CAP256V2LS in Healthy Adults

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Ended earlyNCT00092287
What this trial is testing

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Who this might be right for
Malignant Carcinoid Syndrome
Ipsen 4
Not applicableStudy completedNCT06563648
What this trial is testing

The Effect of Local Cold Application and ShotBlocker Use in Subcutaneous Injection on Injection Pain and Patient Satisfaction

Who this might be right for
PainSatisfaction, Patient
Bornova No. 25 Mevlana Family Health Center 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Early research (Phase 1)Study completedNCT05564221
What this trial is testing

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases

Who this might be right for
Atopic Healthy SubjectsAdult Subjects With Allergic Diseases
Yuhan Corporation 46
Early research (Phase 1)Study completedNCT01443650
What this trial is testing

Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 36
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT01576484
What this trial is testing

Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
HypercholesterolemiaHeterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 58
Early research (Phase 1)Study completedNCT01766245
What this trial is testing

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 28
Early research (Phase 1)Study completedNCT01725620
What this trial is testing

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Who this might be right for
Healthy
LG Life Sciences 48
Early research (Phase 1)Study completedNCT00184613
What this trial is testing

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Delivery Systems
Novo Nordisk A/S 22
Early research (Phase 1)Study completedNCT04653168
What this trial is testing

LY3041658 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 16
Large-scale testing (Phase 3)Looking for participantsNCT07043400
What this trial is testing

Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Metastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
BeOne Medicines 351
Early research (Phase 1)Study completedNCT06167707
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers

Who this might be right for
Heart FailureFluid Overload
scPharmaceuticals, Inc. 21
Large-scale testing (Phase 3)Ended earlyNCT00626600
What this trial is testing

Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

Who this might be right for
Severe Caner Pain
Mundipharma Research Limited 33
Post-approval studies (Phase 4)Study completedNCT03978832
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Who this might be right for
Schizophrenia
Indivior Inc. 69
Load More Results